AlphaGrep UK’s Johnson & Johnson JNJ Stock Holding History

AlphaGrep UK’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$477K	Buy	+1,800	New	+$475K	0.14%	266

Other funds holding JNJ

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

AlphaGrep UK's JNJ Position: Q3 2026 in Review

AlphaGrep UK increased its Johnson & Johnson (JNJ) stake by 156% in Q3 2026, buying an estimated $374K and bringing the position to 2,325 shares worth $616K. The position accounts for 0.18% of the portfolio, ranked #151.

AlphaGrep UK first reported a position in JNJ in Q4 2025 and has held it in 4 quarters since. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

AlphaGrep UK held 2,325 shares of Johnson & Johnson worth $616K as of Q3 2026.
AlphaGrep UK bought 1,416 Johnson & Johnson shares in Q3 2026, an estimated $374K.
Johnson & Johnson made up 0.18% of AlphaGrep UK's portfolio in Q3 2026, its #151 holding.
AlphaGrep UK first reported a position in Johnson & Johnson in Q4 2025 and has held it in 4 quarters since.
4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.